Bryan Heart

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Bryan Heart sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Bryan Heart: 1 sponsored US clinical trial, 1 recruiting.

Bryan Heart sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Anticipatory Guidance, with 1 trials.

Mid-pack sponsor footprint

Bryan Heart is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING

Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

NCT06823583

Therapeutic Areas

Anticipatory Guidance 1
Advanced Heart Failure 1
Ventricular Assist Device 1

What is open in the Bryan Heart pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Anticipatory Guidance (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Bryan Heart: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Bryan Heart sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Bryan Heart1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Bryan Heart sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Bryan Heart sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Bryan Heart page

1 registered trials is a research-attention snapshot, not an endorsement of Bryan Heart or any single study.

  • 1 of Bryan Heart's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anticipatory Guidance is the condition Bryan Heart studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anticipatory Guidance trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Bryan Heart pipeline card: 1 registered trials from official public datasets.Report a data error.